CDR-132L

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameCDR-132L
Drug Alias NameCDR132LNN6706NN-6706
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMicroRNA 132 inhibitors
TargetsMicroRNA 132
Therapy Area/IndicationsMyocardial InfarctionHeart Failure, DiastolicHeart Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCardior Pharmaceuticals Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/SCardior Pharmaceuticals Gmbh
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionHeart Failure
Inactive IndicationsHeart Failure, DiastolicCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A